Clinical Trial

Impact of tDCS on Cannabis Craving in Schizophrenia

Study acronym: tCCS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the tDCS's impact on cannabis craving in patients with schizophrenia and cannabis addiction disorder.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-03-23.
Status change: Recruiting → Not Yet Recruiting 2024-02-15
Trial Details
NCT Number NCT05784961
Lead Sponsor Centre hospitalier de Ville-Evrard, France
Conditions Schizophrenia, Cannabis Use Disorder
Enrollment 138 participants
Start Date 2024-03-01
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-06-20 (estimated)
Updated on ClinicalTrials.gov 2024-02-16